Latest News

In June 2026, a key FDA advisory committee unanimously recommended approval of Moderna’s mRNA-based influenza vaccine, mFlusiva (mRNA-1010), for adults aged 50 and older after late-stage data showed it was about 27% more effective than a standard flu shot. This vote not only advances what could become the first mRNA flu vaccine but also reinforces confidence in Moderna’s broader shift beyond COVID-19 into respiratory, oncology, and rare-disease applications of its mRNA platform. We’ll now...

Index additions put National Vision Holdings in focus National Vision Holdings (EYE) was recently added to several Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth, an index change that can reshape how institutions and index funds approach the stock. See our latest analysis for National Vision Holdings. The index additions come after a sharp short term rebound in National Vision Holdings, with a 7 day share price return of 13.29% and 30 day share price...

After a difficult year in which Intuit stock has fallen 66.2%, the valuation picture now looks more forgiving on several checks, even as legal questions and AI driven competition keep many investors cautious. Over the past 12 months, Intuit shares are down 66.2%, which has reset expectations and brought valuation to the forefront for anyone still following the story. Ongoing restructuring and AI investment may support future earnings power, but securities fraud investigations around TurboTax...

REA Group Ltd. has confirmed that independent Non-executive Director Kelly Bayer Rosmarin will retire from the Board at the October 8, 2026 AGM, after nearly five years of service and membership on the Audit, Risk & Compliance Committee, to focus on her full-time executive role. Her planned departure, alongside the Board’s search for a new independent Non-executive Director, highlights ongoing governance reshaping at a time when REA’s capital management, property listing trends and broader...

In late June 2026, XPO, Inc. (NYSE:XPO) was removed from several Russell indices, including the Russell 3000 Value, Russell 2500, and Russell 1000 Value benchmarks, following the annual reconstitution. This broad index removal reshapes who can hold the stock in index-tracking portfolios, potentially altering XPO’s institutional investor mix and trading patterns. We’ll now examine how XPO’s broad removal from Russell indices may influence its existing investment narrative around technology,...

IonQ stock has delivered a very strong 5 year return, yet its current valuation screens as expensive, so investors are now weighing a powerful growth story against a set of signals that point to a rich price tag. IonQ has returned about 406% over the past 5 years, which puts recent swings into context and shows how stretched sentiment can become after a long run. On the one hand, ambitious quantum computing and security ambitions backed by sizeable cash reserves can support high...

Par Pacific Holdings Stock Performance Snapshot Par Pacific Holdings (PARR) has drawn investor attention after recent trading, with the stock last closing at US$56.08. Returns have been mixed, with gains over the past week but a decline over the past 3 months. See our latest analysis for Par Pacific Holdings. Looking beyond the latest move, Par Pacific Holdings shows a strong year-to-date share price return of 56.56%, while its 1-year total shareholder return of 99.15% points to momentum that...

Index removals reshape how some investors access Wayfair stock Wayfair (W) was removed from several Russell growth benchmarks on June 27, a shift that can affect index linked fund holdings and help explain any unusual trading around the stock. For investors, index deletions like this matter because many institutional portfolios and passive funds track these benchmarks and adjust their positions mechanically. When a stock exits multiple indices at once, related buying or selling can cluster...

Hesai Group recently attracted investor attention as optimism grew around its advanced LiDAR technology and its role in autonomous mobility and ADAS markets. Beyond the technology itself, investors appear focused on Hesai’s solid cash position and momentum among buyers as potential supports for its expansion plans. We’ll now examine how this renewed confidence in Hesai’s LiDAR adoption prospects may influence the company’s existing investment narrative and risks. The best AI stocks today may...

Lenovo Group recently expanded its Hybrid AI Advantage portfolio, unveiling new inference-optimized platforms and agentic AI innovations built with partners including NVIDIA, Intel, Red Hat, and Canonical to help enterprises deploy and manage private AI more efficiently across hybrid environments. By tightly integrating hardware, software, and services into validated architectures that emphasize cost control, security, and faster AI deployment, Lenovo is positioning its AI infrastructure and...

US lawmakers have opened a bipartisan investigation into AbbVie (NYSE:ABBV) over clinical trial activity in China. The probe focuses on possible national security and ethical risks, including research ties to facilities linked to China's military. Congress is also scrutinizing AbbVie trials in sensitive regions such as Xinjiang and potential exposure of patient and research data. AbbVie is a large US-based pharmaceutical company with a global footprint in drug development and clinical...

Albany International Corp. was recently added to the Russell 2000 Dynamic Index, formally recognizing the company as part of this widely followed small‑cap benchmark. This index inclusion could broaden Albany’s investor base and trading liquidity, potentially making its engineered composites and machine clothing businesses more visible to institutional investors. With Albany now in the Russell 2000 Dynamic Index, we’ll examine how this broader visibility may influence its existing investment...

Herbalife stock has delivered a steep decline of around 75% over the past five years, yet on current checks it screens as undervalued, which sets up a clear question over whether recent share price strength is finally bringing it closer to a more reasonable level or leaving some upside on the table. Over the past five years, Herbalife shareholders have seen the share price fall about 75%, which means even the recent rebound sits against a long period of value erosion. The new Herbalife and...

Carpenter Technology has delivered very large multi year gains for shareholders, yet its latest valuation checks flag the stock as expensive rather than a clear bargain. After a sharp run, investors are weighing rich pricing against strong aerospace related momentum highlighted in recent commentary. Carpenter Technology has returned about 16.4x over the past 5 years, which puts extra focus on whether today’s price still leaves room for an attractive risk return trade off. Recent investor...

What Photronics’ Index Additions Could Mean for Investors Photronics (PLAB) has been added to multiple Russell growth and small cap benchmarks, an event that can attract index-linked capital as funds rebalance and traders reassess the stock’s role in portfolios. See our latest analysis for Photronics. Recent trading suggests momentum for Photronics has cooled over the past quarter, with the share price down 20.37% over 90 days. However, the 1-year total shareholder return is 61.44%, which...

Smartbroker Holding (XTRA:SB1) has just posted its FY 2025 first half figures, with revenue of €32.5 million and a basic EPS loss of €0.31. This places a clear focus on how the business is balancing growth with profitability. The company has seen revenue move from €25.7 million in the first half of 2024 to €26.9 million in the second half of 2024 and now €32.5 million in the first half of 2025. EPS has shifted from a loss of €0.12 in early 2024 to a small profit of €0.04 in late 2024 before...

Johnson & Johnson reported new clinical data for IMAAVY (nipocalimab) in generalized myasthenia gravis, including sustained improvement in early stage and less symptomatic patients. The data also showed maintained disease control following infections, a key issue for long-term treatment persistence in this condition. The company announced plans for PETUNIA, a real-world pregnancy safety study, to build evidence on IMAAVY use during pregnancy. Johnson & Johnson, traded as NYSE:JNJ, is...

Energy Transfer has delivered a very strong 166.2% return over the past 5 years, yet on most basic valuation checks the stock still screens as inexpensive. This raises a clear question about how much of its recent progress is already reflected in the price. A 166.2% gain over 5 years suggests Energy Transfer has already rewarded long term holders. Any new position or added exposure therefore rests on whether that momentum can be justified by current and future cash flows. Growth projects...

IperionX has been awarded up to US$6.6 million by the U.S. Department of Defense to scale ballistic-grade titanium plate and component production at its Titanium Manufacturing Campus in Virginia, alongside new prototype and purchase orders for titanium fasteners for military vehicles. This combination of government funding and initial defense orders underscores IperionX’s role in supporting domestic supply chains for advanced titanium components in critical land and maritime programs...

Google’s €2b antitrust blow in Sweden has put a fresh spotlight on European fintech, from digital payments to AI driven shopping and price comparison services such as Klarna’s PriceRunner. With regulators leaning in and legal outcomes reshaping competitive power, some stocks now sit closer to the action than others. This article looks at how that court ruling and the broader pressure on big tech could filter through to listed European fintech companies exposed to these trends. You will see 3...

With housing policy gridlock, rising energy costs, and pressure on household budgets from higher healthcare premiums and tariffs, real estate investment trusts are caught in the crosscurrents of some powerful macro forces. The REITs screener used here focuses on larger companies in the US, UK, Canada, Australia, and New Zealand with solid balance sheet and dividend characteristics and direct links to income producing real estate. This article walks through 3 stocks that appear particularly...

Celsius Holdings stock is in a tricky spot for valuation right now, with the share price weak over recent years while broader checks still suggest the stock is not a clear bargain. Recent legal and regulatory scrutiny around its Alani Nu energy drinks has added another layer of uncertainty on top of already cautious market sentiment. Over the past 3 years, Celsius Holdings has delivered a total return that is down about 41%, which shows how much optimism has already come out of the share...

What Prosus investors are watching after the latest update Prosus (ENXTAM:PRX) has just wrapped up a major capital return phase, combining a multi year buyback with a higher proposed cash distribution, at the same time as reporting its latest full year earnings. This mix of capital returns and fresh financials gives you several angles to assess, from how the completed buyback might affect per share metrics to what the new distribution means if you hold different Prosus share classes. See our...

AXT stock has delivered an extremely strong 1 year return while the broader valuation checks currently lean expensive. This raises the question of how much of the AI and optical networking enthusiasm is already reflected in the price. AXT has returned 3,486.1% over the past year, a very large move that leaves little room for disappointment if expectations reset. Expectations around AI data center and optical networking demand, supported by capacity expansion plans and a record backlog, can...